HUP9802580A2 - Növekedésihormon-felszabadító tulajdonsággal rendelkező vegyületek - Google Patents

Növekedésihormon-felszabadító tulajdonsággal rendelkező vegyületek

Info

Publication number
HUP9802580A2
HUP9802580A2 HU9802580A HUP9802580A HUP9802580A2 HU P9802580 A2 HUP9802580 A2 HU P9802580A2 HU 9802580 A HU9802580 A HU 9802580A HU P9802580 A HUP9802580 A HU P9802580A HU P9802580 A2 HUP9802580 A2 HU P9802580A2
Authority
HU
Hungary
Prior art keywords
atom
growth hormone
independently
compounds
alkyl
Prior art date
Application number
HU9802580A
Other languages
English (en)
Inventor
Michael Ankersen
Thomas Kruse Hansen
Jesper Lau
Behrend Friedrich Lundt
Kjeld Madsen
Bernd Peschke
Brett Watson
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of HUP9802580A2 publication Critical patent/HUP9802580A2/hu
Publication of HUP9802580A3 publication Critical patent/HUP9802580A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
    • B41J—TYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS
    • B41J19/00—Character- or line-spacing mechanisms
    • B41J19/18—Character-spacing or back-spacing mechanisms; Carriage return or release devices therefor
    • B41J19/20—Positive-feed character-spacing mechanisms
    • B41J19/202—Drive control means for carriage movement
    • B41J19/205—Position or speed detectors therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)

Abstract

A találmány tárgya az egy (I) általánős képletű vegyület, ahől R1 és R2 egymástól függetlenül hidrőgénatőm vagy arilcsőpőrttaltetszőlegesen szűbsztitűált 1-6 szénatőmős alkilcsőpőrt, a és b értéke egymástól függetlenül 1 vagy 2, G és J jelentése hidrőgénatőm, -O-(CH2)k-R27 általánős képletű csőpőrt,vagy egy benzőlgyűrűvel kőndenzált, vagy nem kőndenzált arőmás gyűrű,amely heterőatőmként N-atőmőt, vagy S-atőmőt tartalmazhat, R27 jelentése hidrőgén-, halőgénatőm, 1-6 szénatőmős alkil-, vagyalkőxicsőpőrt, k jelentése 0, 1 vagy 2, D jelentése többek között szűbsztitűált piperidinilcsőpőrt, tetra-hidrő-izőkinőlinil-csőpőrt, vagy (3) általánős képletű csőpőrt, ahől R3, R7,R8 és R9 jelentése egymástól függetlenül hidrőgénatőm, vagyhalőgénatőm, aminő-, hidrőxil- vagy arilcsőpőrttal szűb- sztitűáltalkilcsőpőrt, p jelentése 0 vagy 1, q jelentése 0, 1, 2 vagy 3. A találmány tárgyát képező új vegyületek a növekedési hőrmőn hiányábólszármazó rendellenességek kezelésére szőglálnak. ŕ
HU9802580A 1995-12-22 1996-12-16 Compounds with growth hormone releasing properties HUP9802580A3 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK146295 1995-12-22
DK69896 1996-06-25
US2206296P 1996-07-22 1996-07-22
DK81296 1996-07-24
DK124896 1996-11-06
US08/769,020 US5977178A (en) 1995-12-22 1996-12-18 Compounds with growth hormone releasing properties

Publications (2)

Publication Number Publication Date
HUP9802580A2 true HUP9802580A2 (hu) 1999-02-01
HUP9802580A3 HUP9802580A3 (en) 1999-03-29

Family

ID=27545172

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802580A HUP9802580A3 (en) 1995-12-22 1996-12-16 Compounds with growth hormone releasing properties

Country Status (18)

Country Link
US (4) US5977178A (hu)
EP (1) EP0869974B1 (hu)
JP (2) JP3701686B2 (hu)
CN (1) CN1211991A (hu)
AT (1) ATE424412T1 (hu)
AU (1) AU715856B2 (hu)
BR (1) BR9612275A (hu)
CA (1) CA2239711A1 (hu)
CZ (1) CZ195098A3 (hu)
DE (1) DE69637855D1 (hu)
ES (1) ES2323159T3 (hu)
HU (1) HUP9802580A3 (hu)
IL (1) IL124702A0 (hu)
MX (1) MX9804830A (hu)
NO (1) NO982872L (hu)
PL (1) PL327227A1 (hu)
TW (1) TW480248B (hu)
WO (1) WO1997023508A1 (hu)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE272069T1 (de) 1995-01-27 2004-08-15 Novo Nordisk As Verbindungen mit wachstumshormon-freisetzenden eigenschaften
EP0869974B1 (en) * 1995-12-22 2009-03-04 Novo Nordisk A/S Compounds with growth hormone releasing properties
DE69734215T2 (de) * 1996-07-22 2006-06-29 Novo Nordisk A/S Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften
US6117841A (en) * 1997-05-30 2000-09-12 Warner-Lambert Company Substituted peptidylamine calcium channel blockers
EP1005484A1 (en) 1997-06-20 2000-06-07 Novo Nordisk A/S Compounds with growth hormone releasing properties
US6127341A (en) * 1997-06-20 2000-10-03 Novo Nordisk A/S Compounds with growth hormone releasing properties
UA64751C2 (uk) 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
US6083908A (en) * 1998-01-16 2000-07-04 Novo Nordisk A/S Compounds with growth hormone releasing properties
JP4382279B2 (ja) * 1998-01-16 2009-12-09 サファイア セラピューティクス，インコーポレイティド 成長ホルモン放出特性を有する化合物
JP2002505340A (ja) * 1998-03-03 2002-02-19 ノボ ノルディスク アクティーゼルスカブ （２ｅ）−５−アミノ−５−メチルヘキセ−２−エン酸ｎ−メチル−ｎ−（（１ｒ）−１−（ｎ−メチル−ｎ−（（１ｒ）−１−（メチルカルバモイル）−２−フェニルエチル）カルバモイル）−２−（２−ナフチル）エチル）アミドの新規な塩
US6281247B1 (en) 1998-03-03 2001-08-28 Novo Nordisk A/S Salt forms of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphthyl)ethyl)amide
US6784158B1 (en) * 1998-06-09 2004-08-31 Novo Nordisk A/S Method for preparing a compound with growth hormone releasing properties
WO1999067235A1 (fr) * 1998-06-25 1999-12-29 Sumitomo Pharmaceuticals Co., Ltd. Composes cycliques a cinq elements
US6919315B1 (en) 1998-06-30 2005-07-19 Novo Nordisk A/S Compounds with growth hormone releasing properties
DK1100824T3 (da) * 1998-06-30 2011-06-20 Helsinn Therapeutics Us Inc Forbindelser med væksthormonfrigivende egenskaber
ATE272651T1 (de) * 1998-11-03 2004-08-15 Novo Nordisk As Verbindungen mit wachstumshormon-freisetzender eigenschaft
US6566337B1 (en) 1998-11-03 2003-05-20 Novo Nordisk A/S Compounds with growth hormone releasing properties
AU759022B2 (en) 1999-02-18 2003-04-03 Kaken Pharmaceutical Co., Ltd. Novel amide derivatives as growth hormone secretagogues
US6518292B1 (en) * 1999-03-12 2003-02-11 Bristol-Myers Squibb Co. Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
WO2000064845A1 (fr) * 1999-04-22 2000-11-02 Sankyo Company, Limited Cetoamides porteurs de resine et leur procede de preparation
AU6913700A (en) * 1999-08-18 2001-03-13 Schering Aktiengesellschaft Piperidine and pyrrolidine derivatives displaying neuronal activity
US20010020012A1 (en) * 2000-02-01 2001-09-06 Andersen Maibritt Bansholm Use of compounds for the regulation of food intake
ATE446758T1 (de) 2000-05-31 2009-11-15 Pfizer Prod Inc Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts
US7425537B2 (en) * 2000-08-22 2008-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services SH2 domain binding inhibitors
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
AU2003265398A1 (en) 2002-08-09 2004-02-25 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
MY139563A (en) * 2002-09-04 2009-10-30 Bristol Myers Squibb Co Heterocyclic aromatic compounds useful as growth hormone secretagogues
EP1407779A1 (en) 2002-10-10 2004-04-14 Gastrotech A/S Use of ghrelin for treating low body weight and body fat in gastrectomized individuals
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2005014534A1 (en) 2003-08-08 2005-02-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions, and methods of use
US7208601B2 (en) 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
EP1735055A1 (en) * 2004-03-30 2006-12-27 Sapphire Therapeutics, Inc. Method of reducing c-reactive protein using growth hormone secretagogues
ES2388501T3 (es) * 2004-08-12 2012-10-16 Helsinn Healthcare S.A. Uso de secretagogos de la hormona de crecimiento para estimular la motilidad del sistema gastrointestinal
EP1757290A1 (en) 2005-08-16 2007-02-28 Zentaris GmbH Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
PT2118123E (pt) 2007-01-31 2016-02-10 Harvard College Péptidos de p53 estabilizados e suas utilizações
JP2010518090A (ja) 2007-02-09 2010-05-27 トランザイム・ファーマ，インコーポレイテッド 大環状グレリン受容体修飾因子およびその使用方法
MX2009008561A (es) * 2007-02-13 2010-01-15 Helsinn Therapeutics Us Inc Metodo para tratar trastornos proliferativos celulares utilizando secretagogos.
WO2008121767A2 (en) 2007-03-28 2008-10-09 President And Fellows Of Harvard College Stitched polypeptides
TWI429436B (zh) * 2007-04-10 2014-03-11 Helsinn Therapeutics Us Inc 使用生長激素促泌素治療或預防嘔吐之方法
WO2010009389A1 (en) * 2008-07-17 2010-01-21 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Use of targeted nitroxide agents in preventing, mitigating and treating radiation injury
WO2010009327A1 (en) 2008-07-17 2010-01-21 University Of Pittsburgh Of The Commonwealth System Of Higher Education Compounds for the treatment of pathologies associated with aging and degenerative disorders
UA105657C2 (uk) 2009-02-27 2014-06-10 Хелсінн Терапьютікс (Ю.Ес.), Інк. Поліпшені способи лікування мігрені на основі анамореліну
WO2010141824A2 (en) 2009-06-05 2010-12-09 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Use of targeted nitroxide agents in bone healing
RU2582678C2 (ru) 2010-08-13 2016-04-27 Эйлерон Терапьютикс, Инк. Пептидомиметические макроциклы
EP2431035A1 (en) 2010-09-16 2012-03-21 Æterna Zentaris GmbH Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors
ES2834093T3 (es) 2011-07-21 2021-06-16 Sumitomo Dainippon Pharma Oncology Inc Inhibidores de proteína quinasa heterocíclicos
TWI643868B (zh) 2011-10-18 2018-12-11 艾利倫治療公司 擬肽巨環化合物
JP6450191B2 (ja) 2012-02-15 2019-01-09 エイルロン セラピューティクス，インコーポレイテッド ペプチドミメティック大環状化合物
EP2819688A4 (en) 2012-02-15 2015-10-28 Aileron Therapeutics Inc TRIAZOL AND THIOETHER-COUPLED PEPTIDOMIMETIC MACROCYCLES
WO2014071241A1 (en) 2012-11-01 2014-05-08 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
KR20170058424A (ko) 2014-09-24 2017-05-26 에일러론 테라퓨틱스 인코포레이티드 펩티드모방 거대고리 및 이의 용도
JP2018516844A (ja) 2015-03-20 2018-06-28 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ペプチド模倣大環状分子およびその使用
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions
CN113412262A (zh) 2019-02-12 2021-09-17 大日本住友制药肿瘤公司 包含杂环蛋白激酶抑制剂的制剂
CN112724052B (zh) * 2021-01-21 2021-09-07 南京艾美斐生物医药科技有限公司 一种gpr101蛋白受体抑制剂及其制备和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007519A1 (en) * 1992-09-25 1994-04-14 Smithkline Beecham Corporation Growth hormone releasing peptides
WO1995017423A1 (en) * 1993-12-23 1995-06-29 Novo Nordisk A/S Compounds with growth hormone releasing properties
DE4421052A1 (de) * 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
ATE272069T1 (de) * 1995-01-27 2004-08-15 Novo Nordisk As Verbindungen mit wachstumshormon-freisetzenden eigenschaften
EP0869974B1 (en) * 1995-12-22 2009-03-04 Novo Nordisk A/S Compounds with growth hormone releasing properties

Also Published As

Publication number Publication date
US6127391A (en) 2000-10-03
US20030055261A1 (en) 2003-03-20
US5977178A (en) 1999-11-02
PL327227A1 (en) 1998-12-07
MX9804830A (es) 1998-09-30
NO982872L (no) 1998-08-21
NO982872D0 (no) 1998-06-19
AU715856B2 (en) 2000-02-10
EP0869974A1 (en) 1998-10-14
ES2323159T3 (es) 2009-07-07
JP4130519B2 (ja) 2008-08-06
AU1092997A (en) 1997-07-17
BR9612275A (pt) 1999-07-13
EP0869974B1 (en) 2009-03-04
HUP9802580A3 (en) 1999-03-29
JP3701686B2 (ja) 2005-10-05
US20030040483A1 (en) 2003-02-27
WO1997023508A1 (en) 1997-07-03
JPH11209336A (ja) 1999-08-03
CZ195098A3 (cs) 1998-10-14
CN1211991A (zh) 1999-03-24
DE69637855D1 (de) 2009-04-16
IL124702A0 (en) 1998-12-06
CA2239711A1 (en) 1997-07-03
ATE424412T1 (de) 2009-03-15
TW480248B (en) 2002-03-21
US6555570B2 (en) 2003-04-29
US6939880B2 (en) 2005-09-06
JP2000143613A (ja) 2000-05-26
JPH11501054A (ja) 1999-01-26

Similar Documents

Publication Publication Date Title
HUP9802580A2 (hu) Növekedésihormon-felszabadító tulajdonsággal rendelkező vegyületek
HUP9902471A2 (hu) Piperazin- és piperidinvegyületek, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
HUP9800295A2 (hu) Szubsztituált heterociklusos vegyületek, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények, intermedierjeik
HUP9903707A2 (hu) 17Béta-karboxi-,-tio-karboxi-vagy -amido-androsztánszármazékok laktonszármazékai, előállításuk, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
ATE131470T1 (de) Neue arylethenylenderivate und verfahren zu ihrer herstellung
HUP0301745A2 (hu) Ciklopentánindolok, ezeket tartalmazó gyógyszerkészítmények és a vegyületek alkalmazása
DE69434696D1 (de) Verfahren zur Herstellung von Verbindungen geeignet als Zwischenprodukte
NO931151D0 (no) Fremgangsmaate for fremstilling av nitrogenholdige heterocykliske forbindelser med kondenserte ringer
HUP9700358A2 (hu) Új oxazolidinonszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
HUP9800417A2 (hu) 5-Szubsztituált-3-(1,2,3,6-tetrahidro-piridin-4-il)-1H-indolok és 5-szubsztituált-3-(piridin-4-il)-1H-indolok, alkalmazásuk mint új 5-HT agonisták, a vegyületeket tartalmazó gyógyszerkészítmények
HUP0000762A2 (hu) 2-Amino-6-(2-szubsztituált-4-fenoxi)piridin-származékok, valamint a vegyületeket tartalmazó gyógyászati készítmények
HUP0002300A2 (hu) 4-Kinolinkarboxamid-származékok, előállításuk, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
ATE73790T1 (de) Amino 5,6,7,8tetrahydronaphtho(2,3b>furanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
HUP0000321A2 (hu) NOS inhibitor hatású aromás aminszármazékok, eljárás előállításukra, valamint a vegyületeket tartalmazó gyógyszerkészítmények
HUP9904067A2 (hu) A G-protein-funkció gátlására és daganatos betegségek kezelésére alkalmazható triciklusos vegyületek
HUP0001165A2 (hu) NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra
HUP9800649A2 (hu) Benzil-oxi-csoporttal helyettesített, kondenzált N-heterociklusos vegyületek, eljárás előállításukra és alkalmazásuk bradikinin receptorantagonistaként
HUP9800085A2 (hu) Eljárás karbonilvegyületek redukálására és alfa-amino-alkohol-származékok előállítására
ZA929697B (en) Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase.
ES471458A1 (es) Procedimiento para la obtencion de 1,3-diazaciclopent-2-eno 2,1-b-(1-tia-3-aza-cicloalcanos)
EP0001560A3 (en) Uv-light-stabilized compositions containing substituted 1,5-diazacycloalkanes and 2-keto-1,5-diazacycloalkanes, novel compounds and synthesis thereof
HUP9904096A2 (hu) Eljárás szubsztituált fenil-piridinek előállítására
HUP9902157A2 (hu) Eljárás és intermedierek 4'-trifluor-metil-bifenil-2-karbonsav-[2-(2H-[1,2,4]-triazol-3-il-metil)-1,2,3,4-tetrahidro-izokinolin-6-il]-amid előállítására
HUP0401573A2 (hu) Eljárás kinazolinszármazékok előállítására
HUP9700983A2 (hu) 1,4-Diaril-2-fluor-2-butén-származékok, intermedierjeik, előállításuk és alkalmazásuk, valamint hatóanyagként ezeket a vegyületeket tartalmazó inszekticid és akaricid készítmények